APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Blood Substitute

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

Selected research

Market Outlook & Growth Opportunities

Global Artificial Blood Substitute Market Outlook and Growth Opportunities 2026

28 December 2025192 pages

Choose your research edition.

Industry ResearchArtificial Blood Substitute Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Blood Substitute Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Artificial Blood Substitute Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Blood Substitute Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Blood Substitute Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.

Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .

Read the full market overview

This report provides an overview of the global Artificial Blood Substitute market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Blood Substitute and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Blood Substitute revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Artificial Blood Substitute market.

Artificial Blood Substitute Segment by Company

Aurum Biosciences Ltd.

HEMARINA SA

HbO2 Therapeutics

KaloCyte Inc.

SpheriTech Ltd.

NuvOx Pharma

Artificial Blood Substitute Segment by Type

Perfluorocarbon-based Oxygen Carrier (PFBOC)

Hemoglobin-based Oxygen Carrier (HBOC)

Artificial Blood Substitute Segment by Application

Military

Civil

Artificial Blood Substitute Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Blood Substitute status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Artificial Blood Substitute key companies, revenue, market share, and recent developments.

3. To split the Artificial Blood Substitute breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Artificial Blood Substitute market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Blood Substitute significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Blood Substitute competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Substitute market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Substitute and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Substitute.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Blood Substitute industry.

Chapter 3: Detailed analysis of Artificial Blood Substitute company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Artificial Blood Substitute in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Artificial Blood Substitute in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Blood Substitute Industry Trends Table 2. Artificial Blood Substitute Industry Drivers Table 3. Artificial Blood Substitute Industry Opportunities and Challenges Table 4. Artificial Blood Substitute Industry Restraints Table 5. Global Artificial Blood Substitute Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Blood Substitute Revenue Share by Company (2021-2026) Table 7. Global Artificial Blood Substitute Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Artificial Blood Substitute Key Company Manufacturing Base & Headquarters Table 9. Global Artificial Blood Substitute Company, Product Type & Application Table 10. Global Artificial Blood Substitute Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Artificial Blood Substitute by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Perfluorocarbon-based Oxygen Carrier (PFBOC) Table 15. Significant Companies of Hemoglobin-based Oxygen Carrier (HBOC) Table 16. Global Artificial Blood Substitute Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Artificial Blood Substitute Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Artificial Blood Substitute Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Artificial Blood Substitute Sales Value Share by Type (2021-2026) Table 20. Global Artificial Blood Substitute Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Military Table 22. Significant Companies of Civil Table 23. Global Artificial Blood Substitute Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Artificial Blood Substitute Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Artificial Blood Substitute Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Artificial Blood Substitute Sales Value Share by Application (2021-2026) Table 27. Global Artificial Blood Substitute Sales Value Share by Application (2027-2032) Table 28. Global Artificial Blood Substitute Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Artificial Blood Substitute Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Artificial Blood Substitute Sales Value Share by Region (2021-2026) Table 31. Global Artificial Blood Substitute Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Artificial Blood Substitute Sales Value Share by Region (2027-2032) Table 33. Global Artificial Blood Substitute Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Artificial Blood Substitute Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Artificial Blood Substitute Sales Value Market Share by Country (2021-2026) Table 36. Global Artificial Blood Substitute Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Artificial Blood Substitute Sales Value Market Share by Country (2027-2032) Table 38. Aurum Biosciences Ltd. Company Information Table 39. Aurum Biosciences Ltd. Business Overview Table 40. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Aurum Biosciences Ltd. Artificial Blood Substitute Product Portfolio Table 42. Aurum Biosciences Ltd. Recent Development Table 43. HEMARINA SA Company Information Table 44. HEMARINA SA Business Overview Table 45. HEMARINA SA Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. HEMARINA SA Artificial Blood Substitute Product Portfolio Table 47. HEMARINA SA Recent Development Table 48. HbO2 Therapeutics Company Information Table 49. HbO2 Therapeutics Business Overview Table 50. HbO2 Therapeutics Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. HbO2 Therapeutics Artificial Blood Substitute Product Portfolio Table 52. HbO2 Therapeutics Recent Development Table 53. KaloCyte Inc. Company Information Table 54. KaloCyte Inc. Business Overview Table 55. KaloCyte Inc. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. KaloCyte Inc. Artificial Blood Substitute Product Portfolio Table 57. KaloCyte Inc. Recent Development Table 58. SpheriTech Ltd. Company Information Table 59. SpheriTech Ltd. Business Overview Table 60. SpheriTech Ltd. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. SpheriTech Ltd. Artificial Blood Substitute Product Portfolio Table 62. SpheriTech Ltd. Recent Development Table 63. NuvOx Pharma Company Information Table 64. NuvOx Pharma Business Overview Table 65. NuvOx Pharma Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. NuvOx Pharma Artificial Blood Substitute Product Portfolio Table 67. NuvOx Pharma Recent Development Table 68. Research Programs/Design for This Report Table 69. Authors List of This Report Table 70. Secondary Sources Table 71. Primary Sources List of Figures Figure 1. Artificial Blood Substitute Product Image Figure 2. Global Artificial Blood Substitute Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Blood Substitute Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Perfluorocarbon-based Oxygen Carrier (PFBOC) Image Figure 8. Hemoglobin-based Oxygen Carrier (HBOC) Image Figure 9. Global Artificial Blood Substitute Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Artificial Blood Substitute Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Artificial Blood Substitute Sales Value Share by Type (2021-2032) Figure 12. Military Image Figure 13. Civil Image Figure 14. Global Artificial Blood Substitute Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Artificial Blood Substitute Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Artificial Blood Substitute Sales Value Share by Application (2021-2032) Figure 17. Global Artificial Blood Substitute Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Artificial Blood Substitute Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Artificial Blood Substitute Sales Value (2021-2032) & (US$ Million) Figure 20. North America Artificial Blood Substitute Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Artificial Blood Substitute Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Artificial Blood Substitute Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Artificial Blood Substitute Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Artificial Blood Substitute Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Artificial Blood Substitute Sales Value (2021-2032) & (US$ Million) Figure 26. South America Artificial Blood Substitute Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Artificial Blood Substitute Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Artificial Blood Substitute Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Artificial Blood Substitute Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Applications
  • Military
  • Civil
Companies covered
  • Aurum Biosciences Ltd.
  • HEMARINA SA
  • HbO2 Therapeutics
  • KaloCyte Inc.
  • SpheriTech Ltd.
  • NuvOx Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Blood Substitute Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Blood Substitute Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Artificial Blood Substitute Market Dynamics
  1. 2.1 Artificial Blood Substitute Industry Trends
  2. 2.2 Artificial Blood Substitute Industry Drivers
  3. 2.3 Artificial Blood Substitute Industry Opportunities and Challenges
  4. 2.4 Artificial Blood Substitute Industry Restraints
3 Artificial Blood Substitute Market by Company
  1. 3.1 Global Artificial Blood Substitute Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Blood Substitute Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Blood Substitute Company Ranking (2024-2026)
  4. 3.4 Global Artificial Blood Substitute Company Manufacturing Base and Headquarters
  5. 3.5 Global Artificial Blood Substitute Company Product Type and Application
  6. 3.6 Global Artificial Blood Substitute Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Artificial Blood Substitute Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Artificial Blood Substitute Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Artificial Blood Substitute Market by Type
  1. 4.1 Artificial Blood Substitute Type Introduction
  2. 4.1.1 Perfluorocarbon-based Oxygen Carrier (PFBOC)
  3. 4.1.2 Hemoglobin-based Oxygen Carrier (HBOC)
  4. 4.2 Global Artificial Blood Substitute Sales Value by Type
  5. 4.2.1 Global Artificial Blood Substitute Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artificial Blood Substitute Sales Value by Type (2021-2032)
  7. 4.2.3 Global Artificial Blood Substitute Sales Value Share by Type (2021-2032)
5 Artificial Blood Substitute Market by Application
  1. 5.1 Artificial Blood Substitute Application Introduction
  2. 5.1.1 Military
  3. 5.1.2 Civil
  4. 5.2 Global Artificial Blood Substitute Sales Value by Application
  5. 5.2.1 Global Artificial Blood Substitute Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Artificial Blood Substitute Sales Value by Application (2021-2032)
  7. 5.2.3 Global Artificial Blood Substitute Sales Value Share by Application (2021-2032)
6 Artificial Blood Substitute Regional Value Analysis
  1. 6.1 Global Artificial Blood Substitute Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Blood Substitute Sales Value by Region (2021-2032)
  3. 6.2.1 Global Artificial Blood Substitute Sales Value by Region: 2021-2026
  4. 6.2.2 Global Artificial Blood Substitute Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Blood Substitute Sales Value (2021-2032)
  7. 6.3.2 North America Artificial Blood Substitute Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Artificial Blood Substitute Sales Value (2021-2032)
  10. 6.4.2 Europe Artificial Blood Substitute Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Artificial Blood Substitute Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Artificial Blood Substitute Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Artificial Blood Substitute Sales Value (2021-2032)
  16. 6.6.2 South America Artificial Blood Substitute Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Artificial Blood Substitute Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Artificial Blood Substitute Sales Value Share by Country, 2025 VS 2032
7 Artificial Blood Substitute Country-level Value Analysis
  1. 7.1 Global Artificial Blood Substitute Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Blood Substitute Sales Value by Country (2021-2032)
  3. 7.2.1 Global Artificial Blood Substitute Sales Value by Country (2021-2026)
  4. 7.2.2 Global Artificial Blood Substitute Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Artificial Blood Substitute Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Artificial Blood Substitute Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Artificial Blood Substitute Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aurum Biosciences Ltd.
  2. 8.1.1 Aurum Biosciences Ltd. Company Information
  3. 8.1.2 Aurum Biosciences Ltd. Business Overview
  4. 8.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Portfolio
  6. 8.1.5 Aurum Biosciences Ltd. Recent Developments
  7. 8.2 HEMARINA SA
  8. 8.2.1 HEMARINA SA Company Information
  9. 8.2.2 HEMARINA SA Business Overview
  10. 8.2.3 HEMARINA SA Artificial Blood Substitute Revenue and Gross Margin (2021-2026)
  11. 8.2.4 HEMARINA SA Artificial Blood Substitute Product Portfolio
  12. 8.2.5 HEMARINA SA Recent Developments
  13. 8.3 HbO2 Therapeutics
  14. 8.3.1 HbO2 Therapeutics Company Information
  15. 8.3.2 HbO2 Therapeutics Business Overview
  16. 8.3.3 HbO2 Therapeutics Artificial Blood Substitute Revenue and Gross Margin (2021-2026)
  17. 8.3.4 HbO2 Therapeutics Artificial Blood Substitute Product Portfolio
  18. 8.3.5 HbO2 Therapeutics Recent Developments
  19. 8.4 KaloCyte Inc.
  20. 8.4.1 KaloCyte Inc. Company Information
  21. 8.4.2 KaloCyte Inc. Business Overview
  22. 8.4.3 KaloCyte Inc. Artificial Blood Substitute Revenue and Gross Margin (2021-2026)
  23. 8.4.4 KaloCyte Inc. Artificial Blood Substitute Product Portfolio
  24. 8.4.5 KaloCyte Inc. Recent Developments
  25. 8.5 SpheriTech Ltd.
  26. 8.5.1 SpheriTech Ltd. Company Information
  27. 8.5.2 SpheriTech Ltd. Business Overview
  28. 8.5.3 SpheriTech Ltd. Artificial Blood Substitute Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SpheriTech Ltd. Artificial Blood Substitute Product Portfolio
  30. 8.5.5 SpheriTech Ltd. Recent Developments
  31. 8.6 NuvOx Pharma
  32. 8.6.1 NuvOx Pharma Company Information
  33. 8.6.2 NuvOx Pharma Business Overview
  34. 8.6.3 NuvOx Pharma Artificial Blood Substitute Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NuvOx Pharma Artificial Blood Substitute Product Portfolio
  36. 8.6.5 NuvOx Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst